Welcome to the UPF Digital Repository

Prevalencia e incidencia de hiperpotasemia en población española con insuficiencia cardiaca con fracción de eyección deprimida: revisión sistemática y relevancia poblacional

Show simple item record

dc.contributor.author Hernáez, Álvaro
dc.contributor.author Delgado, Juan F.
dc.contributor.author Cinca, Juan
dc.contributor.author Fernández-Avilés, Francisco
dc.contributor.author Marrugat de la Iglesia, Jaume
dc.date.accessioned 2019-01-18T08:24:16Z
dc.date.available 2019-01-18T08:24:16Z
dc.date.issued 2018
dc.identifier.citation Hernáez Á, Delgado JF, Cinca J, Fernández-Avilés F, Marrugat J. Prevalencia e incidencia de hiperpotasemia en población española con insuficiencia cardiaca con fracción de eyección deprimida: revisión sistemática y relevancia poblacional. Rev Clin Esp. 2018 Jun-Jul;218(5):253-260. DOI: 10.1016/j.rce.2018.01.006
dc.identifier.issn 0014-2565
dc.identifier.uri http://hdl.handle.net/10230/36322
dc.description.abstract BACKGROUND AND OBJECTIVES: Hyperkalaemia (K+ levels≥5.5mmol/L) is a severe ion imbalance that occurs in patients who have heart failure (HF) with reduced ejection fraction (HFrEF) and increases the risk of ventricular fibrillation. Given that there are no estimates on the number of patients with this complication, the aim of this study was to estimate the prevalence and incidence of hyperkalaemia in patients with HFrEF in Spain. MATERIAL AND METHODS: Based on a systematic literature search and through a meta-analysis, we calculated an HFrEF prevalence of ≤40% in the European and U.S. POPULATION: Based on another systematic literature search, we calculated the prevalence of hyperkalaemia in patients with HF and its annual incidence rate. Considering the previous values and the Spanish population pyramid in 2016, we estimated the number of individuals with HFrEF who currently have hyperkalaemia and those who develop it each year in Spain. RESULTS: Approximately 17,100 (10,000 men and 7100 women) of the 508,000 patients with HFrEF in Spain have hyperkalaemia. Furthermore, approximately 14,900 patients with HFrEF (9500 men and 5400 women) develop hyperkalaemia each year. CONCLUSIONS: Approximately 1 of every 30 patients with HFrEF has plasma potassium values >5.5 mmol/L.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartof Revista Clínica Española. 2018 Jun-Jul;218(5):253-60
dc.rights © Elsevier http://dx.doi.org/10.1016/j.rce.2018.01.006
dc.title Prevalencia e incidencia de hiperpotasemia en población española con insuficiencia cardiaca con fracción de eyección deprimida: revisión sistemática y relevancia poblacional
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.1016/j.rce.2018.01.006
dc.subject.keyword Chronic heart failure
dc.subject.keyword Estimate
dc.subject.keyword Hiperpotasemia
dc.subject.keyword Hyperkalaemia
dc.subject.keyword Incidence
dc.subject.keyword Incidencia
dc.subject.keyword Insuficiencia cardíaca crónica
dc.subject.keyword Potasio
dc.subject.keyword Potassium
dc.subject.keyword Prevalence
dc.subject.keyword Prevalencia
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/acceptedVersion

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking